eLife selects outstanding papers for 2013

Drug Resistance

In a bid to shake up the luxury journal cabal, the journal eLife was launched in late 2012 to give researchers a high-quality open-access publishing option that, in addition to having a world-class editorial board, also supports early career scientists and provides open and rigorous peer review.

For the second half of 2013, the academic editors of eLife chose five outstanding papers to highlight original research by early career scientists.   Among these was our paper on fitness benefits and fitness costs in drug-resistant Salmonella Typhi, written with Stephen Baker’s research group.   Stephen was funded by eLife to present his work at the Wellcome Trust.

Baker et al, eLife, 2013